Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Clin Invest Med ; 39(3): E95-E104, 2016 06 16.
Article de Anglais | MEDLINE | ID: mdl-27439688

RÉSUMÉ

PURPOSE: Stroke is the third most common cause of mortality worldwide and is a major cause of permanent disability. The purposed of the study was to better understand the risk factors for poor outcomes following ischemic stroke requiring treatment. METHODS: Three hundred seventy patients with first-event ischemic stroke were enrolled. Good outcomes was defined as a using the Modified Rankin Scale (MRS) score ≤3 without any cardiovascular event, while poor outcomes were any of the following end points: MRS >3 at 3 months, recurrent stroke or death. Prognostic variables for poor outcomes were analyzed based on a stepwise logistic regression model. RESULTS: Seventy-eight patients had poor outcomes (21%, 78/370), assessed at a minimum of six-month follow-up. Higher mean National Institutes of Health Stroke Scale (NIHSS) scores at presentation, presence of early neurologic deterioration (END) and higher mean high-sensitivity C-reactive protein (hs-CRP) levels were associated with poor outcomes at discharge. Furthermore, both NIHSS at presentation and the presence of END were associated with poor outcomes, assessed at a minimum of six-month follow-up. CONCLUSION: A higher mean initial NIHSS score implies not only severe neurologic deficits but also an increased risk of poor outcomes. Since END following ischemic stroke is frequently associated with poor outcomes, more attention should be directed to providing adequate treatment to patients in the acute stage, especially for high risk patients.


Sujet(s)
Imagerie par résonance magnétique , Accident vasculaire cérébral/imagerie diagnostique , Accident vasculaire cérébral/thérapie , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Encéphalopathie ischémique/imagerie diagnostique , Encéphalopathie ischémique/thérapie , Protéine C-réactive/composition chimique , Études cas-témoins , Collecte de données , Femelle , Humains , Mâle , Adulte d'âge moyen , Pronostic , Analyse de régression , Études rétrospectives , Facteurs de risque , Indice de gravité de la maladie , Résultat thérapeutique , Jeune adulte
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE